Evolution of the Average Target: DarioHealth Corp.

Evolution of the Average Target - DarioHealth Corp.

Evolution of the Target Price: DarioHealth Corp.

Evolution of the Target Price - DarioHealth Corp.

Changes in Analyst Recommendations: DarioHealth Corp.

5265892bc76b1da3480a5e.9QTDFHp9Dl0IN7xbUV83t_61RaZu3RF9yzbdBCzGUyA.pGugcBE5OyxsXt4eMBAC-LeNPeIE61ovnxu0fVqcAFO6crpgFApmNTh97Q~87c75fefcdf34557f1832416391e83ab
25-09-25 DarioHealth Corp. Initiates A Comprehensive Strategic Review to Maximize Shareholder Value CI
25-08-12 Digital therapeutics platform DarioHealth Q2 revenue falls steeper-than-expected 14% RE
25-01-29 TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2 MT
23-08-11 Alliance Global Adjusts Price Target on DarioHealth to $4.10 From $5.45, Keeps Buy Rating MT
23-07-25 Stifel Nicolaus Adjusts DarioHealth Price Target to $6 From $9, Maintains Buy Rating MT
23-05-12 Craig-Hallum Adjusts DarioHealth's Price Target to $8 From $14, Keeps Buy Rating MT
22-11-16 Alliance Global Partners Adjusts Price Target on DarioHealth to $7.50 From $9.15, Maintains Buy Rating MT
22-08-18 Aegis Capital Adjusts DarioHealth's Price Target to $15 from $20, Keeps Buy Rating MT
22-08-16 Stifel Nicolaus Adjusts DarioHealth Price Target to $11 From $15, Maintains Buy Rating MT
22-08-16 Cowen Adjusts Trims Price Target on DarioHealth to $14 From $18, Keeps Outperform Rating MT
22-08-15 Craig-Hallum Lowers Price Target for DarioHealth to $14 From $18, Maintains Buy Rating MT
22-05-16 Aegis Capital Adjusts DarioHealth's Price Target to $20 from $23, Keeps Buy Rating MT
22-05-16 Cowen Adjusts DarioHealth's Price Target to $18 from $14, Keeps Outperform Rating MT
22-05-13 Alliance Global Upgrades DarioHealth to Buy From Neutral, Keeps $8.75 Price Target MT
22-01-26 Aegis Capital Adjusts DarioHealth Price Target to $25 From $28, Maintains Buy Rating MT
21-08-19 DarioHealth : Aegis Capital Adjusts Price Target on DarioHealth to $28 From $35, Maintains Buy Rating MT
21-08-17 DarioHealth : Cantor Fitzgerald Adjusts DarioHealth's Price Target to $30 from $35, Keeps Overweight Rating MT
21-08-17 DarioHealth : Alliance Global Adjusts DarioHealth's Price Target to $12.75 From $15.25, Maintains Neutral Rating MT
21-05-24 DarioHealth : Alliance Global Adjusts DarioHealth's Price Target to $15.25 From $18.25, Maintains Neutral Rating MT
21-04-22 DarioHealth : Cowen Starts DarioHealth at Outperform With $31 Price Target MT
21-03-23 DarioHealth : Stifel Starts DarioHealth at Buy With $30 Price Target MT
21-02-25 DarioHealth : Cantor Fitzgerald Starts DarioHealth at Overweight With $35 Price Target MT
21-02-01 DarioHealth : Alliance Global Partners Downgrades DarioHealth to Neutral From Buy, Adjusts PT to $22.25 From $15.60 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+260.74%
+14.29%
+18.06%
+9.65%
+19.16%
+11.51%
+17.34%
-1.68%
+24.56%
+29.2%
Average +40.28%
Weighted average by Cap. +14.89%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
3.770USD
Average target price
13.60USD
Spread / Average Target
+260.74%
High Price Target
28.00USD
Spread / Highest target
+642.71%
Low Price Target
8.000USD
Spread / Lowest Target
+112.20%

Analyst Consensus Detail

Analyst consensus - DarioHealth Corp.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - DarioHealth Corp.
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - DarioHealth Corp.
  1. Stock Market
  2. Stocks
  3. DRIO Stock
  4. Consensus DarioHealth Corp.